Key Highlights
• A contract research organisation, also known as a clinical research organisation, is a company that assists sponsor companies with overseeing complex clinical research and trial responsibilities, clinical commercialization and development of new products, and developing drugs, solely in the field of biotechnology medical device, and pharmaceutical industries. Among other research services, these organisations provide clinical trial administration, preclinical studies, clinical investigation, commercialization, and pharmacovigilance. These are outsourced under contract, commonly known as fee-for-service.
• The Worldwide Contract Research Organisation Market was worth USD 70.69 billion by 2022, and it is expected to be worth USD 170.11 billion in 2032. Over the projection period, the Global Market is expected to develop at CAGR of 12.67%.
• Mar’22 - Argenx SE & IQVIA cooperated to investigate novel applications for VYVGART in adult patients with myasthenia gravis. The collaboration is expected to help speed the development of additional indications for VYVGART by supporting the development of clinical, commercials, governing, and real-world evidence strategies. This method strengthens the company's long-term commercial partnerships while also extending its client base.
• Pharmaceutical and biotechnology firms are driving the Contract Research Organization Market by leasing clinical research. The CRO industry has grown significantly in recent years, spurred by the quest for faster and more effective drug development. Competition for research services in clinical trials is expected to rise throughout the estimated time period due to an increase in the number of new drug releases and increased R&D spending. Additionally, the growing emphasis on medication advancement and research, along with the desire to reduce delivery time as well as expenses related to developing new drugs, are driving the rise of this business.
Scope of the Industry Profile
Key Players
• Charles River Laboratories
• Envigo
• ICON Plc
• IQVIA
• Laboratoty Corporation of America Holdings (Labcorp)
• MedPace Holdings Inc.
• PSI CRO AG
• Thermo Fisher Scientific
• SGS SA
• Syneos Health
• WuXi Pharmatech
• Axcent Advanced Analytics (A3)
• BIO Agile Therapeutics
What To Expect from Industry Profile
1. Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the Contract Research Organization market in the world.
2. Use the PORTER’s Five Forces analysis to determine the competitive intensity and therefore market attractiveness of the global Contract Research Organization market.
3. Leading company profiles reveal details of key Contract Research Organization market players’ global operations, strategies, financial performance & their recent developments.
4. Add weight to presentations and pitches by understanding the future growth prospects of the Global Contract Research Organization market with forecast for decade by both market share (%) & revenue (USD Million).
Segmentation
By End Users
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes
By Type
• Clinical Research Services
• Early Phase Development Services
• Laboratory Services
• Consulting Services
• Data Management Services
By Clinical Research Services
• Phase I
• Phase II
• Phase III
• Phase IV
By Early Phase Development Services
• Chemistry
• Manufacturing & Controls Services
• Preclinical Services
• Pharmacokinetics/ Pharmacodynamics Services
• Toxicology Testing Services
• Other Preclinical Services
• Discovery Studies
By Therapeutic Areas
• Infectious Diseases
• Neurology
• Metabolic Disorders/Endocrinology
• Immunological Disorders
• Respiratory Disorders
• Dermatology
• Ophthalmology
• Gastrointestinal Diseases
• Genitourinary & Women's Health
• Hematology
• Other Therapeutic Areas
Recent Developments
• Nov’22 - IQVIA & Clalit Health Services cooperated to combine clinical trials the delivery process, the real-world investigation, information, and genomics capabilities.
• Oct’22 - Thermo Fisher Scientific's PPD clinical research division created the Decentralised Clinical Trials Networks to assist worldwide investigators and research facilities engaging in decentralised clinical trials (DCTs).
• Oct’22 - Walmart (US) is developing a new medical research organisation in order to promote higher-quality, more egalitarian healthcare. The primary focus of Walmart Health Research Institute will be on promoting diversity in clinical research for pharmaceuticals that treat chronic conditions.
Segment Insights
• Clinical research services have the largest market share of the global CRO market by type segment. This segment is predicted to increase at the fastest rate during the projection period. The continued outsourced of research in clinical trials by biotechnology and pharmaceutical firms is fueling the market's rise.
• In End User Segment, pharmaceutical & biotechnological category held the largest percentage of the global CRO market in 2021, owing to growing investment in research and development by pharmaceutical and biotechnology companies, rising demand for outsourced services, and an increase in the number of clinical trials being conducted globally.
• Oncology is the largest and fastest-growing category in therapeutic area segment. Oncology contract research organisations (CROs) offer an extensive variety of services to help with the development of drugs, from preclinical studies to clinical studies and beyond.
Regional Insights
• North America accounted for the greatest share of the worldwide CRO market in 2022, accounting for approximately 65-70% of total market revenue. It can be ascribed to the region's growing number of clinical trials, as well as the existence of a high number of CROs in nations including the Canada & US.
• With a projected 20-22% stake in the worldwide market in 2022, the European area is projected to be the second-biggest marketplace for CROs. This is due to factors such as the region's growing number of biopharmaceutical businesses and favorable reimbursement regulations for clinical trials.
• The Asia-Pacific area is predicted to develop at the quickest rate during the period of forecasting, at a CAGR of approximately 9.0%. This is due to reasons such as rising medical expenses, increased government financing for clinical studies, and an increase in the number of individuals struggling with chronic diseases.
1 INTRODUCTION
1.1 Study Objectives
1.2 Market Definitions
1.2.1 Inclusions & Exclusions
1.2.2 Region: Inclusions & Exclusions
1.2.3 Study Scope
1.2.3.1 Markets Covered
1.2.3.2 Regional Scope
1.2.3.3 Years Considered
1.2.4 Currency Considered
1.2.5 Limitations
1.2.6 Summary Of Report (Chapter Wise Summary)
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary & Primary Research
2.1.2 Secondary Data
2.1.2.1 Secondary Sources
2.1.3 Primary Data
2.1.3.1 Primary Sources
2.2 Market Breakdown & Data Triangulation
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Research Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 EXECUTIVE SUMMARY
4 ACROSS THE GLOBE
4.1 Upcoming Attractive Market Opportunities
4.2 Country Wise Market Growth
4.3 Segment Wise Market Growth
5 MARKET OVERVIEW
5.1 Market Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Restraints
5.2.3 Opportunities
5.2.4 Challenges
5.3 PORTOR’S Five Forces Analysis
5.3.1 Threat of New Entrants
5.3.2 Threat of Substitutes
5.3.3 Bargaining Power of Suppliers
5.3.4 Bargaining Power of Buyers
5.3.5 Intensity of Competitive Rivalry
5.4 Market Premium insights (Enterprise license)
5.4.1 Case Study Analysis
5.4.2 Country Wise Import & Export Data (If
Applicable)
5.4.3 Regulatory Bodies & Authorization
Across the Globe
5.4.4 Key Conferences & Events: 2022 &
2023
5.4.5 Top Patents for The Market: 2022
6 CONTRACT RESEARCH ORGANIZATION
MARKET OVERVIEW, BY END USERS
6.1 Global Market Revenue & Share Analysis, By End Users
6.1.1 Pharmaceutical & Biopharmaceutical
Companies
6.1.2 Medical Device Companies
6.1.3 Academic Institutes
6.2 Global Market Revenue & Share Analysis, 2018 – 2022
6.3 Global Market Revenue & Share Forecast Analysis, 2023 –
2032
6.4 Key Takeaways
7 CONTRACT RESEARCH ORGANIZATION
MARKET OVERVIEW, BY TYPE
7.1 Global Market Revenue & Share Analysis, By Type
7.1.1 Clinical Research Services
7.1.2 Early Phase Development Services
7.1.3 Laboratory Services
7.1.4 Consulting Services
7.1.5 Data Management Services
7.2 Global Market Revenue & Share Analysis, 2018 – 2022
7.3 Global Market Revenue & Share Forecast Analysis, 2023 –
2032
7.4 Key Takeaways
8 CONTRACT RESEARCH ORGANIZATION
MARKET OVERVIEW, BY CLINICAL RESEARCH SERVICES
8.1 Global Market Revenue & Share Analysis, By Clinical
Research Services
8.1.1 Phase I
8.1.2 Phase II
8.1.3 Phase III
8.1.4 Phase IV
8.2 Global Market Revenue & Share Analysis, 2018 – 2022
8.3 Global Market Revenue & Share Forecast Analysis, 2023 –
2032
8.4 Key Takeaways
9 CONTRACT RESEARCH
ORGANIZATION MARKET OVERVIEW, BY EARLY PHASE DEVELOPMENT SERVICES
9.1 Global Market Revenue & Share Analysis, By Early Phase
Development Services
9.1.1 Chemistry
9.1.2 Manufacturing & Controls Services
9.1.3 Preclinical Services
9.1.4 Pharmacokinetics/ Pharmacodynamics
Services
9.1.5 Toxicology Testing Services
9.1.6 Other Preclinical Services
9.1.7 Discovery Studies
9.2 Global Market Revenue & Share Analysis, 2018 – 2022
9.3 Global Market Revenue & Share Forecast Analysis, 2023 –
2032
9.4 Key Takeaways
10 CONTRACT RESEARCH ORGANIZATION MARKET
OVERVIEW, BY THERAPEUTIC AREAS
10.1 Global Market Revenue & Share Analysis, By Therapeutic
Areas
10.1.1 Infectious Diseases
10.1.2 Neurology
10.1.3 Metabolic Disorders/Endocrinology
10.1.4 Immunological Disorders
10.1.5 Respiratory Disorders
10.1.6 Dermatology
10.1.7 Ophthalmology
10.1.8 Gastrointestinal Diseases
10.1.9 Genitourinary & Women's Health
10.1.10 Hematology
10.1.11 Other Therapeutic Areas
10.2 Global Market Revenue & Share Analysis, 2018 – 2022
10.3 Global Market Revenue & Share Forecast Analysis, 2023 –
2032
10.4 Key Takeaways
11 CONTRACT RESEARCH ORGANIZATION MARKET
OVERVIEW, BY REGION
11.1 Global Market Revenue & Share Analysis, By Region
11.1.1 North America
11.1.2 Europe
11.1.3 Asia Pacific
11.1.4 Middle East & Africa
11.1.5 South America
11.2 Global Market Revenue & Share Analysis, 2018 – 2022
11.3 Global Market Revenue & Share Forecast Analysis, 2023 –
2032
11.4 Key Takeaways
12 NORTH AMERICA MARKET
ANALYSIS
12.1 North America Market Revenue & Share Analysis, By End
Users
12.2 North America Market Revenue & Share Analysis, By Type
12.3 North America Market Revenue & Share Analysis, By Clinical
Research Services
12.4 North America Market Revenue & Share Analysis, By Early
Phase Development Services
12.5 North America Market Revenue & Share Analysis, By
Therapeutic Areas
12.6 North America Market Revenue & Share Analysis, By Country
12.6.1 US
12.6.2 Canada
12.6.3 Mexico
12.7 Key Takeaways
13 EUROPE MARKET ANALYSIS
13.1 Europe Market Revenue & Share Analysis, By End Users
13.2 Europe Market Revenue & Share Analysis, By Type
13.3 Europe Market Revenue & Share Analysis, By Clinical
Research Services
13.4 Europe Market Revenue & Share Analysis, By Early Phase
Development Services
13.5 Europe Market Revenue & Share Analysis, By Therapeutic
Areas
13.6 Europe Market Revenue & Share Analysis, By Country
13.6.1 UK
13.6.2 Italy
13.6.3 Spain
13.6.4 Germany
13.6.5 France
13.6.6 Rest of Europe
13.7 Key Takeaways
14 ASIA PACIFIC MARKET ANALYSIS
14.1 APAC Market Revenue & Share Analysis, By End Users
14.2 APAC Market Revenue & Share Analysis, By Type
14.3 APAC Market Revenue & Share Analysis, By Clinical Research
Services
14.4 APAC Market Revenue & Share Analysis, By Early Phase
Development Services
14.5 APAC Market Revenue & Share Analysis, By Therapeutic Areas
14.6 APAC Market Revenue & Share Analysis, By Country
14.6.1 China
14.6.2 Japan
14.6.3 India
14.6.4 South Korea
14.6.5 Rest of APAC
14.7 Key Takeaways
15 MIDDLE EAST & AFRICA MARKET
ANALYSIS
15.1 MEA Market Revenue & Share Analysis, By End Users
15.2 MEA Market Revenue & Share Analysis, By Type
15.3 MEA Market Revenue & Share Analysis, By Clinical Research
Services
15.4 MEA Market Revenue & Share Analysis, By Early Phase
Development Services
15.5 MEA Market Revenue & Share Analysis, By Therapeutic Areas
15.6 MEA Market Revenue & Share Analysis, By Country
15.6.1 GCC
15.6.2 South Africa
15.6.3 Rest of MEA
15.7 Key Takeaways
16 SOUTH AMERICA MARKET ANALYSIS
16.1 SA Market Revenue & Share Analysis, By End Users
16.2 SA Market Revenue & Share Analysis, By Type
16.3 SA Market Revenue & Share Analysis, By Clinical Research
Services
16.4 SA Market Revenue & Share Analysis, By Early Phase
Development Services
16.5 SA Market Revenue & Share Analysis, By Therapeutic Areas
16.6 SA Market Revenue & Share Analysis, By Country
16.6.1 Brazil
16.6.2 Argentina
16.6.3 Rest of SA
16.7 Key Takeaways
17 COMPETITIVE SCENARIO
17.1 Overview
17.2 Key Players Market Share Analysis
17.3 Recent Developments & Product Launches
17.4 Mergers & Acquisitions
17.5 Partnerships, Agreements & Collaborations
18 COMPANY PROFILES
18.1 Overview
18.2 Key players
18.2.1 Charles River Laboratories
18.2.1.1 Business Overview
18.2.1.2 Products Offered
18.2.1.3 Financial Insights
18.2.1.4 Strategic Developments
18.2.1.4.1 New Product Launches
18.2.1.4.2 Agreements & Collaborations
18.2.1.5 Business Aspects (NOISE Analysis)
18.2.1.5.1 Key Strengths
18.2.1.5.2 Opportunities
18.2.1.5.3 Weaknesses & Competitive Threats
18.2.1.5.4 Needs & Improvements
18.2.2 Envigo
18.2.3 ICON Plc
18.2.4 IQVIA
18.2.5 Laboratoty Corporation of America Holdings
(Labcorp)
18.2.6 MedPace Holdings Inc.
18.2.7 PSI CRO AG
18.2.8 Thermo Fisher Scientific
18.2.9 SGS SA
18.2.10 Syneos Health
19 DISCLAIMER
20 APPENDIX
